SeekingAlpha · Nov 12, 2026
Accendra Health, Inc. 2026 Q3 - Results - Earnings Call Presentation
2026-11-12. The following slide deck was published by Accendra Health, Inc.
NYSE · ACH
Healthcare · Medical - Distribution
$0.09
Down-$0.00 (-3.50%)
Updated Nov 20, 2026, 2:17 AM
SID Score
3.2/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · ACH
1M range · 0 trading sessions · Daily adjusted prices
ACH does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
The latest Smart Investors Daily articles mentioning ACH.
Company
Market Activity
Research & News
ACH research
Company profile and research snapshot.
Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 13, 2026 | UBS | Neutral | — |
| Aug 11, 2026 | Citigroup | Neutral | — |
| Jul 24, 2026 | Citigroup | Buy | — |
| May 12, 2026 | UBS | Neutral | — |
| May 12, 2026 | Citigroup | Buy | — |
No generated briefing is available yet.
SeekingAlpha · Nov 12, 2026
2026-11-12. The following slide deck was published by Accendra Health, Inc.
Yahoo · Nov 6, 2026
Management outlines a turnaround plan as profit improvement falls short of expectations.
Fintel · Nov 6, 2026
Yahoo · Nov 6, 2026
Accendra Health Inc (ACH) posted its first revenue decline of 2026 and warned full-year adjusted EBITDA could come in up to 30% below prior guidance, while outlining a multi-year turnaround plan.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning ACH.